More than a dozen drug companies including Pfizer Inc., Johnson & Johnson, and Sanofi are coordinating their Covid-19 efforts with the NIH to push out new treatments and vaccines.
The public-private partnership plans to develop an international framework for prioritizing vaccine and drug candidates, streamlining clinical trials, coordinating regulatory processes across different countries, and using assets available among all collaborators to respond rapidly to both the current and future pandemics. The National Institutes of Health announced the Accelerating COVID-19 Therapeutic Interventions and Vaccines partnership Friday.
More than 300 clinical trials on Covid-19 are underway, and that number increases almost daily, ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.